This is supported by Li et al., 34, who suggested that the combination of estrogen and ER positivity in developing mammary gland promotes tumor growth and angiogenesis, which is one of the mechanisms by which HRT & OC (oral contraceptive) use affects BC in younger women (33). This evidence concerns the gene ESR1 and breast cancer.